Malignant pleural mesothelioma: current concepts in treatment

May 31, 2007 | Comments Off on Malignant pleural mesothelioma: current concepts in treatment

Nature Clinical Practice Oncology. (2007) 4, 344-352 [Link] Athanasios Tsiouris* and Robin K Walesby Correspondence *Basement flat 2, 359 Camden Road, London N7 0SH, UK Email athtsiouris@hotmail.com Abstract Malignant pleural…

The Rochdale asbestos cancer studies and the politics of epidemiology: what you see depends on where you sit

May 26, 2007 | Comments Off on The Rochdale asbestos cancer studies and the politics of epidemiology: what you see depends on where you sit

International Journal of Occupational and Environmental Health. 2007 Jan-Mar;13(1):70-9. [Link] Tweedale G. Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. marchevsky@cshs.org Abstract The history…

Evidence-based guidelines for the utilization of immunostains in diagnostic pathology: pulmonary adenocarcinoma versus mesothelioma

May 25, 2007 | Comments Off on Evidence-based guidelines for the utilization of immunostains in diagnostic pathology: pulmonary adenocarcinoma versus mesothelioma

Applied Immunohistochemistry & Molecular Morphology. 5(2):140-144, June 2007. [Link] Marchevsky AM, Wick MR. Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. marchevsky@cshs.org Abstract There…

Management options for malignant pleural mesothelioma: clinical and cost considerations

May 25, 2007 | Comments Off on Management options for malignant pleural mesothelioma: clinical and cost considerations

Drugs. 2007;67(8):1149-65. [Link] Goudar RK. Department of Medicine, Duke University Medical Center, Durham, North Carolina 27701, USA. gouda001@mc.duke.edu Abstract Malignant pleural mesothelioma (MPM) is a resistant form of lung cancer…

Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma

May 25, 2007 | Comments Off on Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma

Cancer Chemotherapy and Pharmacology. 2007 May 24; [Epub ahead of print] [Link] Gordon GJ, Mani M, Maulik G, Mukhopadhyay L, Yeap BY, Kindler HL, Salgia R, Sugarbaker DJ, Bueno R.…

Severe cutaneous toxicity after Pemetrexed as second line treatment for a refractory non small cell lung cancer

May 24, 2007 | Comments Off on Severe cutaneous toxicity after Pemetrexed as second line treatment for a refractory non small cell lung cancer

Revue des Maladies Respiratoires. 2007 May;24(5):635-8. [Link] C. Tummino[1], F. Barlesi[1], C. Tchouhadjian[1], A.M. Tasei[2], C. Gaudy-Marqueste[3], M.A. Richard[3], P. Astoul[1] [1] Faculté de Médecine, Université de la Méditerranée-Assistance Publique…

Some Limitations of Aggregate Exposure Metrics

May 22, 2007 | Comments Off on Some Limitations of Aggregate Exposure Metrics

Risk Analysis. Volume 27 Issue 2 Page 439-445, April 2007 [Link] Louis Anthony (Tony) Cox, Jr. and Douglas A. Popken Cox Associates, Inc., 503 Franklin Street, Denver, CO 80218, USA.…

Low prevalence of SV40 in Swiss mesothelioma patients after elimination of false-positive PCR results

May 22, 2007 | Comments Off on Low prevalence of SV40 in Swiss mesothelioma patients after elimination of false-positive PCR results

Lung Cancer. 2007 Sep;57(3):282-91. Epub 2007 May 21. [Link] Annemarie Zieglera, Christian A. Seemayerb, Marc Hinterbergerc, Peter Vogtc, Colette Bigoscha, Oliver Gautschid, Luigi Tornillob, Daniel C. Betticherd, Holger Mochc, Rolf…

A preliminary experimental study of boron neutron capture therapy for malignant tumors spreading in thoracic cavity

May 22, 2007 | Comments Off on A preliminary experimental study of boron neutron capture therapy for malignant tumors spreading in thoracic cavity

Japanese Journal of Clinical Oncology 2007 Apr;37(4):245-9. Epub 2007 May 18. [Link] Minoru Suzuki1,, Yoshinori Sakurai2, Shinichiro Masunaga1, Yuko Kinashi1, Kenji Nagata1, Akira Maruhashi2 and Koji Ono1 1 Particle Oncology…

Pemetrexed in small-cell lung cancer: background and review of the ongoing GALES pivotal trial

May 18, 2007 | Comments Off on Pemetrexed in small-cell lung cancer: background and review of the ongoing GALES pivotal trial

Expert Review of Anticancer Therapy May 2007, Vol. 7, No. 5, Pages 635-640 [Link] Roberta Ferraldeschi, Nick Thatcher and Paul Lorigan Department of Medical Oncology, Christie Hospital NHS Trust, Manchester,…

Categories